Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child.
Abstract
Background: Prenatal exposure to certain anti-seizure medications (ASMs) is associated with an increased risk of major congenital malformations (MCM). The majority of women with epilepsy continue taking ASMs throughout pregnancy and, therefore, information on the potential risks associated with ASM treatment is required.
Objectives: To assess the effects of prenatal exposure to ASMs on the prevalence of MCM in the child.
Citations
Altmetric:
Date
2023-08-29
Type
Evidence Summary
Subject
Neurology, Paediatrics, Obstetrics. Midwifery
Collections
Citation
Cochrane Database Syst Rev . 2023 Aug 29;8(8):CD010224
Journal / Source Title
Cochrane Database of Systematic Reviews
DOI
10.1002/14651858.CD010224.pub3
PMID
37647086
Publisher
Wiley
Publisher’s URL
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463554/